Price $7.67 |
Market Cap
2.8B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.25
|
P/S
1.11
|
Dividend %
-
|
|
P/CF
21.9
|
P/FCF
10.6
|
Op. Cash Flow
285.5K
|
FCF
1.6
|
|
Op. Margin
-156.20%
|
Net Margin
-155.10%
|
ROE
-174.20%
|
ROI
-353.40%
|
|
ROA
-92.50%
|
EPS Growth
59.80%
|
Current Ratio
3.3
|
Debt/Equity
66.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
